MR1 and breast carcinoma: Kishi and colleagues (45) described expansions of HLA-agnostic T cells in the TILs of 2 patients with breast cancer in Japan who responded to MCF-7 breast cancer cells (MR1*01/*02) but not MR1-KO MCF-7 cells.